EICHOR
● Active Not Recruiting
VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
Condition: Atherosclerotic Cardiovascular Disease · Sponsor: Duke University
About this study
VictORION-INCLUSION (V-INCLUSION) seeks to evaluate the effectiveness of inclisiran as an innovative therapy with the potential to help bridge care gaps in historically understudied and undertreated populations by leveraging electronic health records (EHR) in multiple US Healthcare Systems (HCS) to systematically identify those at high risk for and already diagnosed with ASCVD for more expeditious achievement of LDL-C targets.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (23)
| Univ. of Alabama - Birmingham | Birmingham, Alabama, United States | — |
| Univ. of California - Irvine | Orange, California, United States | — |
| San Francisco General Hospital | San Francisco, California, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| Wellstar Paulding | Hiram, Georgia, United States | — |
| Rush University | Chicago, Illinois, United States | — |
| University of Iowa | Iowa City, Iowa, United States | — |
| JHU - Suburban Hospital | Bethesda, Maryland, United States | — |
| Johns Hopkins | Columbia, Maryland, United States | — |
| Essentia Health | Duluth, Minnesota, United States | — |
| University of Missouri | Columbia, Missouri, United States | — |
| Washington University | St Louis, Missouri, United States | — |
+ 11 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06249165